Found 5 matching trials
CT Antigen TCR-redirected T Cells for Ovarian Cancer. PHASE1 This study, will take a subject's "T cells" and "teach" them to be able to ...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors PHASE2 This trial will evaluate safety and efficacy of human engineered T-cell the...
Show More Status
Active Not Recruiting
Location
City of Hope National Medical Center
Learn More & Join Trial
Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in Combination With Anti-Cancer Agents in Relapsed and Refractory Synovial Sarcoma Expressing New York Esophageal Antigen-1 (NY-ESO-1) and/or LAGE-1a PHASE2 Adoptive T-cell therapy is a therapeutic approach that aims to generate an ...
Show More Location
Multiple Locations
Learn More & Join Trial
Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1 Positive Multiple Myeloma PHASE1 This trial will evaluate safety, tolerability, and efficacy of letetresgene...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma PHASE1 The purpose of this early (pilot) clinical trial is to test the effects (bo...
Show More Location
GSK Investigational Site
Learn More & Join Trial